Back to Search
JESSICA KIENAST, PHARMD
PHARMD
Pharmacist
NPI: 1215536669Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
15906-40(WI)
Research & Publications (20)
Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.
PMID 16409457·J Thromb Haemost·2006
3-trial
Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.
PMID 19047294·J Clin Oncol·2009
2-rct
Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myeloma.
PMID 19147757·Clin Cancer Res·2009
8-other
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.
PMID 18724394·Bone Marrow Transplant·2008
4-observational
Intestinal graft-versus-host-disease staging by video capsule endoscopy.
PMID 18633870·Endoscopy·2008
5-case
Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
PMID 18768435·J Clin Oncol·2008
4-observational
Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography.
PMID 18057227·Blood·2008
7-preclinical
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
PMID 18182664·J Clin Oncol·2008
4-observational
Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study.
PMID 17762533·Blood Coagul Fibrinolysis·2007
3-trial
Differential requirement for a cellular type-1 immune response in tumor-associated versus alloantigen-targeted GvT effects.
PMID 17297406·Transplantation·2007
7-preclinical
Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma.
PMID 17614819·Br J Haematol·2007
3-trial
Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia.
PMID 16735702·J Clin Oncol·2006
2-rct
G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis.
PMID 16401694·J Exp Med·2006
7-preclinical
High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety.
PMID 16424704·Crit Care Med·2006
8-other
Immunotherapy of B-cell malignancies with genetically engineered human CD8+ natural killer T cells.
PMID 16437143·Leukemia·2006
8-other
IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
PMID 16540956·Crit Care Med·2006
4-observational
Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin.
PMID 16676077·Thromb Haemost·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 377 N ROLLING MEADOWS DR
FOND DU LAC, WI 54937 - Phone
- (920) 921-9591
Quick Facts
- NPI
- 1215536669
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile